middle.news
Lumos Diagnostics Hits 250 Patient Milestone in Paediatric FebriDx Study
7:35pm on Thursday 14th of May, 2026 AEST
•
Healthcare
Read Story
Lumos Diagnostics Hits 250 Patient Milestone in Paediatric FebriDx Study
7:35pm on Thursday 14th of May, 2026 AEST
Key Points
250 patients enrolled in BARDA-funded paediatric study
US$670,000 milestone payment received, total US$2.59 million to date
Study supports FDA 510(k) clearance and CLIA waiver submission for children
FebriDx US market expanded 15-fold after recent FDA clearance for ages 12-64
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Lumos Diagnostics (ASX:LDX)
OPEN ARTICLE